BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34275765)

  • 1. Effect of Tart Cherry on Aromatase Inhibitor-Induced Arthralgia (AIA) in Nonmetastatic Hormone-Positive Breast Cancer Patients: A Randomized Double-Blind Placebo-Controlled Trial.
    Shenouda M; Copley R; Pacioles T; Lebowicz Y; Jamil M; Akpanudo S; Tirona MT
    Clin Breast Cancer; 2022 Jan; 22(1):e30-e36. PubMed ID: 34275765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927.
    Hershman DL; Unger JM; Crew KD; Awad D; Dakhil SR; Gralow J; Greenlee H; Lew DL; Minasian LM; Till C; Wade JL; Meyskens FL; Moinpour CM
    J Clin Oncol; 2015 Jun; 33(17):1910-7. PubMed ID: 25940724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia.
    Niravath P; Hilsenbeck SG; Wang T; Jiralerspong S; Nangia J; Pavlick A; Ademuyiwa F; Frith A; Ma C; Park H; Rigden C; Suresh R; Ellis M; Kent Osborne C; Rimawi MF
    Breast Cancer Res Treat; 2019 Sep; 177(2):427-435. PubMed ID: 31218477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202.
    Henry NL; Unger JM; Schott AF; Fehrenbacher L; Flynn PJ; Prow DM; Sharer CW; Burton GV; Kuzma CS; Moseley A; Lew DL; Fisch MJ; Moinpour CM; Hershman DL; Wade JL
    J Clin Oncol; 2018 Feb; 36(4):326-332. PubMed ID: 29136387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acupuncture on aromatase inhibitor-induced arthralgia in patients with breast cancer: A meta-analysis of randomized controlled trials.
    Chen L; Lin CC; Huang TW; Kuan YC; Huang YH; Chen HC; Kao CY; Su CM; Tam KW
    Breast; 2017 Jun; 33():132-138. PubMed ID: 28384564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).
    Shen S; Unger JM; Crew KD; Till C; Greenlee H; Gralow J; Dakhil SR; Minasian LM; Wade JL; Fisch MJ; Henry NL; Hershman DL
    Breast Cancer Res Treat; 2018 Dec; 172(3):603-610. PubMed ID: 30159789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the Chinese medicine Yi Shen Jian Gu granules on aromatase inhibitor-associated musculoskeletal symptoms: A randomized, controlled clinical trial.
    Peng N; Yu M; Yang G; Fu Q; Xu Y; Yu J; Liu Q; Li C; Xu W; Zhang Y; Ma C; Yang L; Yu R; Wang X
    Breast; 2018 Feb; 37():18-27. PubMed ID: 29059538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic risk prediction of aromatase inhibitor-related arthralgia in patients with breast cancer using a novel machine-learning algorithm.
    Reinbolt RE; Sonis S; Timmers CD; Fernández-Martínez JL; Cernea A; de Andrés-Galiana EJ; Hashemi S; Miller K; Pilarski R; Lustberg MB
    Cancer Med; 2018 Jan; 7(1):240-253. PubMed ID: 29168353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of neuromuscular taping on musculoskeletal disorders secondary to the use of aromatase inhibitors in breast cancer survivors: a pragmatic randomised clinical trial.
    Conejo I; Pajares B; Alba E; Cuesta-Vargas AI
    BMC Complement Altern Med; 2018 Jun; 18(1):180. PubMed ID: 29890985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acupuncture and Vitamin D for the Management of Aromatase Inhibitor-Induced Arthralgia.
    Anand K; Niravath P
    Curr Oncol Rep; 2019 Apr; 21(6):51. PubMed ID: 30997616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatase inhibitor-induced arthralgia: a review.
    Niravath P
    Ann Oncol; 2013 Jun; 24(6):1443-9. PubMed ID: 23471104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.
    Hershman DL; Unger JM; Greenlee H; Capodice JL; Lew DL; Darke AK; Kengla AT; Melnik MK; Jorgensen CW; Kreisle WH; Minasian LM; Fisch MJ; Henry NL; Crew KD
    JAMA; 2018 Jul; 320(2):167-176. PubMed ID: 29998338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized phase II placebo-controlled study to evaluate the efficacy of topical pure emu oil for joint pain related to adjuvant aromatase inhibitor use in postmenopausal women with early breast cancer: JUST (Joints Under Study).
    Chan A; De Boer R; Gan A; Willsher P; Martin R; Zissiadis Y; Miller K; Bauwens A; Hastrich D
    Support Care Cancer; 2017 Dec; 25(12):3785-3791. PubMed ID: 28691132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102.
    Cathcart-Rake E; Novotny P; Leon-Ferre R; Le-Rademacher J; Storrick EM; Adjei AA; Terstriep S; Glaser R; Giuliano A; Mitchell WR; Page S; Austin C; Deming RL; Ferreira MA; Lafky JM; Birrell SN; Loprinzi CL
    Support Care Cancer; 2021 Jan; 29(1):387-396. PubMed ID: 32372176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic options for aromatase inhibitor-associated arthralgia in breast cancer survivors: A systematic review of systematic reviews, evidence mapping, and network meta-analysis.
    Kim TH; Kang JW; Lee TH
    Maturitas; 2018 Dec; 118():29-37. PubMed ID: 30415752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833).
    Desideri I; Lucidi S; Francolini G; Meattini I; Ciccone LP; Salvestrini V; Valzano M; Morelli I; Angelini L; Scotti V; Bonomo P; Greto D; Terziani F; Becherini C; Visani L; Livi L
    Med Oncol; 2022 Jun; 39(8):113. PubMed ID: 35666314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of aromatase inhibitor-induced arthralgia in breast cancer: a systematic review and meta-analysis.
    Beckwée D; Leysen L; Meuwis K; Adriaenssens N
    Support Care Cancer; 2017 May; 25(5):1673-1686. PubMed ID: 28204994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients.
    Hack CC; Häberle L; Brucker SY; Janni W; Volz B; Loehberg CR; Hartkopf AD; Walter CB; Baake G; Fridman A; Malter W; Wuerstlein R; Harbeck N; Hoffmann O; Kuemmel S; Martin B; Thomssen C; Graf H; Wolf C; Lux MP; Bayer CM; Rauh C; Almstedt K; Gass P; Heindl F; Brodkorb T; Willer L; Lindner C; Kolberg HC; Krabisch P; Weigel M; Steinfeld-Birg D; Kohls A; Brucker C; Schulz V; Fischer G; Pelzer V; Rack B; Beckmann MW; Fehm T; Rody A; Maass N; Hein A; Fasching PA; Nabieva N
    Breast; 2020 Apr; 50():11-18. PubMed ID: 31958661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for the Treatment of Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
    Yang GS; Kim HJ; Griffith KA; Zhu S; Dorsey SG; Renn CL
    Cancer Nurs; 2017; 40(4):E26-E41. PubMed ID: 27333128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors.
    Mao JJ; Stricker C; Bruner D; Xie S; Bowman MA; Farrar JT; Greene BT; DeMichele A
    Cancer; 2009 Aug; 115(16):3631-9. PubMed ID: 19517460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.